Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01220713 · ClinicalTrials.gov registry record · Phase 2
Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)
A Phase 2 study of Mild Traumatic Brain Injury and Post Concussive Syndrome, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT01220713 is a Phase 2 study of Mild Traumatic Brain Injury and Post Concussive Syndrome that has completed, run by Virginia Commonwealth University. The registered enrollment target is 60 participants, below the 219-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT01220713, a Phase 2 study of Mild Traumatic Brain Injury and Post Concussive Syndrome, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this research is to serve as a demonstration project to determine the tolerability of individuals with persistent post-concussive symptoms from combat-related mild TBI (traumatic brain injury), identify dose-finding for HBO2 (Hyperbaric Oxygen) therapy, and determine the efficacy of HBO2 therapy.
Conditions Studied
Interventions
- PROCEDURE Hyperbaric Oxygen Therapy
Study Locations (3)
Virginia
- Naval Medical Center Portsmouth - Portsmouth
- Hunter Holmes McGuire Veterans' Affairs Medical Center - Richmond
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01220713
The ClinicalTrials.gov registry entry for NCT01220713 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (73% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT01220713 reports 3 study locations spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT01220713 about?
NCT01220713 is a clinical study titled "Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)". The goal of this research is to serve as a demonstration project to determine the tolerability of individuals with persistent post-concussive symptoms from combat-related mild TBI (traumatic brain injury), identify dose-finding for HBO2 (Hyperbaric Oxygen) therapy, and determine the efficacy of HBO2...
What is the current status of trial NCT01220713?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2010-06. Estimated completion is 2013-07.
What conditions does trial NCT01220713 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Post Concussive Syndrome.
What interventions are being tested in trial NCT01220713?
The interventions under investigation include: Hyperbaric Oxygen Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT01220713?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01220713 being conducted?
This trial has 3 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
RECRUITING · Phase 2
-
Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms
RECRUITING · Phase 2
-
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History
RECRUITING · Phase 2
-
Pilot rTMS for AUD+mTBI
ACTIVE NOT RECRUITING · Phase 2
-
Concussion Recovery and Support Program
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.